A Suitable Reply to Bill Gates: Covid-19 Health Tech DIYA Vocal BioMarker
At par with the mutation of the SARS-CoV-2 and its variants, global health technologists are leveraging Industry 4.0 technology to determine non-invasive ways of diagnosing Covid-19. Two years ago, the crisis started with the potential discovery of vaccination. When fulfilled, technologists have up their game to vocal biomarkers in a marketplace poised for a CAGR of 15.5% by 2027.
Thinking of innovation, we consider India at the receiving end. India, as per Bill Gates, was not competent enough to manufacture Covid-19 vaccination. Adar Poonawala, the CEO of Serum Institute of India, fought a battle to get Europe to approve international travel from India. They believed that Covishield-vaccinated Indian travelers were unsafe. But now, India has pivoted amidst all challenges, and here's how i...
